{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:52:45Z","timestamp":1771915965159,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FP7 Framework of European Commission"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.12.069","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:59:49Z","timestamp":1453424389000},"page":"1103-1108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Generation of virus-like particles for emerging epizootic haemorrhagic disease virus: Towards the development of safe vaccine candidates"],"prefix":"10.1016","volume":"34","author":[{"given":"Kinda","family":"Alshaikhahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polly","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2015.12.069_bib0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1348-0421.1969.tb00447.x","article-title":"Ibaraki virus, an agent of epizootic disease of cattle resembling bluetongue. I. Epidemiologic, clinical and pathologic observations and experimental transmission to calves","volume":"13","author":"Omori","year":"1969","journal-title":"Jpn J Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.069_bib0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1751-0813.1975.tb00051.x","article-title":"Ibaraki disease and its relationship to bluetongue","volume":"51","author":"Inaba","year":"1975","journal-title":"Aust Vet J"},{"issue":"14","key":"10.1016\/j.vaccine.2015.12.069_bib0210","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/vr.155.14.422","article-title":"Outbreak of epizootic haemorrhagic disease on the island of Reunion","volume":"155","author":"Breard","year":"2004","journal-title":"Vet Rec"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.069_bib0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0021-9975(77)90023-8","article-title":"Infection of British deer and farm animals with epizootic haemorrhagic disease of deer virus","volume":"87","author":"Gibbs","year":"1977","journal-title":"J Comp Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.069_bib0220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3201\/eid1502.080572","article-title":"Epizootic hemorrhagic disease in cattle Western Turkey","volume":"15","author":"Temizel","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2015.12.069_bib0225","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1099\/vir.0.015651-0","article-title":"Detection of a novel reassortant epizootic hemorrhagic disease virus (EHDV) in the USA containing RNA segments derived from both exotic (EHDV-6) and endemic (EHDV-2) serotypes","volume":"91","author":"Allison","year":"2010","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.069_bib0230","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7589\/0090-3558-40.3.383","article-title":"Epizootiology of an epizootic hemorrhagic disease outbreak in West Virginia","volume":"40","author":"Gaydos","year":"2004","journal-title":"J Wildl Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.069_bib0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/vr.162.2.53","article-title":"Epizootic haemorrhagic disease virus type 7 infection in cattle in Israel","volume":"162","author":"Yadin","year":"2008","journal-title":"Vet Rec"},{"issue":"12","key":"10.1016\/j.vaccine.2015.12.069_bib0240","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/JCM.37.12.3800-3803.1999","article-title":"Identification and PCR-restriction fragment length polymorphism analysis of a variant of the Ibaraki virus from naturally infected cattle and aborted fetuses in Japan","volume":"37","author":"Ohashi","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.069_bib0245","first-page":"21","article-title":"Bluetongue virus structural components","volume":"162","author":"Huismans","year":"1990","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.069_bib0250","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.10.4.783-794.1972","article-title":"Structure of the bluetongue virus capsid","volume":"10","author":"Verwoerd","year":"1972","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.069_bib0255","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0168-1702(91)90081-6","article-title":"Complete nucleotide sequence of segment 5 of epizootic haemorrhagic disease virus; the outer capsid protein VP5 is homologous to the VP5 protein of bluetongue virus","volume":"20","author":"Iwata","year":"1991","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.069_bib0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0042-6822(92)90187-T","article-title":"Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horse sickness, bluetongue, and epizootic hemorrhagic disease as evidenced by their capsid protein sequences","volume":"191","author":"Iwata","year":"1992","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.069_bib0265","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/JVI.66.4.2135-2142.1992","article-title":"Three-dimensional structure of single-shelled bluetongue virus","volume":"66","author":"Prasad","year":"1992","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.069_bib0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/1047-8477(92)90068-L","article-title":"Structure of bluetongue virus particles by cryoelectron microscopy","volume":"109","author":"Hewat","year":"1992","journal-title":"J Struct Biol"},{"issue":"15","key":"10.1016\/j.vaccine.2015.12.069_bib0275","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1128\/JVI.78.15.8059-8067.2004","article-title":"Interactions between the inner and outer capsids of bluetongue virus","volume":"78","author":"Nason","year":"2004","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2015.12.069_bib0280","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.0913403107","article-title":"Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.069_bib0285","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/JVI.64.4.1530-1536.1990","article-title":"Synthesis of bluetongue virus (BTV) core like particles by a recombinant baculovirus expressing the two major structural core proteins of BTV","volume":"64","author":"French","year":"1990","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.12.069_bib0290","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jsbi.1994.1019","article-title":"Structure of correctly self-assembled bluetongue virus-like particles","volume":"112","author":"Hewat","year":"1994","journal-title":"J Struct Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2015.12.069_bib0295","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1128\/JVI.64.12.5695-5700.1990","article-title":"Assembly of double-shelled, virus like particles of bluetongue virus by the simultaneous expression of four structural proteins","volume":"64","author":"French","year":"1990","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.069_bib0300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0264-410X(92)90415-G","article-title":"Protective efficacy of virus-like particles for bluetongue disease","volume":"10","author":"Roy","year":"1992","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2015.12.069_bib0305","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0264-410X(94)90289-5","article-title":"Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection","volume":"12","author":"Roy","year":"1994","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2015.12.069_bib0310","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.vaccine.2012.01.042","article-title":"Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection","volume":"30","author":"Stewart","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.069_bib0315","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1093\/nar\/gng006","article-title":"Improving baculovirus recombination","volume":"31","author":"Zhao","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2015.12.069_bib0320","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1099\/0022-1317-68-5-1233","article-title":"Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins","volume":"68","author":"Matsuura","year":"1987","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2015.12.069_bib0325","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/JVI.67.8.4566-4579.1993","article-title":"Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli","volume":"67","author":"Luckow","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.069_bib0330","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2199-10-87","article-title":"Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA","volume":"10","author":"Noad","year":"2009","journal-title":"BMC Mol Biol"},{"issue":"17","key":"10.1016\/j.vaccine.2015.12.069_bib0335","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.vaccine.2009.10.072","article-title":"Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus","volume":"28","author":"Stewart","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.069_bib0340","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0042-6822(87)90280-7","article-title":"Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4","volume":"157","author":"Mertens","year":"1987","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.069_bib0345","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0042-6822(80)90339-6","article-title":"The in vitro activation and further characterization of the bluetongue virus-associated transcriptase","volume":"104","author":"Van Dijk","year":"1980","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2015.12.069_bib0350","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1128\/JVI.65.9.4821-4831.1991","article-title":"Synthesis and characterization of chimeric particles between epizootic hemorrhagic disease virus and bluetongue virus: functional domains are conserved on the VP3 protein","volume":"65","author":"Le Blois","year":"1991","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.vaccine.2015.12.069_bib0355","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1128\/JVI.74.18.8658-8669.2000","article-title":"Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assembly","volume":"74","author":"Limn","year":"2000","journal-title":"J Virol"},{"issue":"5947","key":"10.1016\/j.vaccine.2015.12.069_bib0360","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/307178a0","article-title":"Human hepatitis B vaccine from recombinant yeast","volume":"307","author":"McAleer","year":"1984","journal-title":"Nature"},{"issue":"9744","key":"10.1016\/j.vaccine.2015.12.069_bib0365","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.vaccine.2015.12.069_bib0370","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"issue":"9518","key":"10.1016\/j.vaccine.2015.12.069_bib0375","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"40","key":"10.1016\/j.vaccine.2015.12.069_bib0380","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1016\/j.vaccine.2013.06.087","article-title":"Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle","volume":"31","author":"Anggraeni","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.069_bib0385","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7589\/0090-3558-40.1.119","article-title":"Epizootiology of hemorrhagic disease in mule deer in central Arizona","volume":"40","author":"Dubay","year":"2004","journal-title":"J Wildl Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.12.069_bib0390","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.virusres.2009.07.012","article-title":"Genetic and phylogenetic analysis of the outer-coat proteins VP2 and VP5 of epizootic haemorrhagic disease virus (EHDV): comparison of genetic and serological data to characterise the EHDV serogroup","volume":"145","author":"Anthony","year":"2009","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T07:28:32Z","timestamp":1600068512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X16000190"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of virus-like particles for emerging epizootic haemorrhagic disease virus: Towards the development of safe vaccine candidates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}